Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neonatology

Can CMV Pass Through Breast Milk? What Parents Should Know

At a Glance

CMV can be passed through breast milk, but breastfeeding is generally safe for healthy, full-term babies. Very premature, very low-birth-weight, or medically fragile infants have a higher risk of serious illness and may need processed milk, donor milk, or formula under NICU guidance.

The Bottom Line: For a healthy, full-term baby, breastfeeding is generally safe and encouraged even if you have had CMV. For a very premature, very low-birth-weight, or medically fragile baby, you will need to work with your Neonatal Intensive Care Unit (NICU) to decide if your breast milk should be used fresh, frozen, pasteurized, or temporarily replaced.

Yes, cytomegalovirus (CMV) can be passed to a baby through breast milk [1]. Up to 80% of mothers with a history of CMV will shed the virus in their breast milk at some point during lactation [2]. However, the level of concern depends mainly on your baby’s gestational age, birth weight, and overall health [3].

What Does Being “CMV-Positive” Mean?

When doctors say a mother is “CMV-positive,” they usually mean she is CMV-seropositive—meaning a blood test shows antibodies (IgG) from a past CMV infection. It does not necessarily mean you have an active illness [4].

Even if you have these antibodies, it does not mean every drop of your milk is infectious. Viral shedding in breast milk often peaks in the early weeks after birth and then declines [1].

Note on Timing: It is also important to distinguish between postnatal CMV (acquired after birth through milk) and congenital CMV (passed during pregnancy). If there is concern your baby might have congenital CMV, doctors usually need to test your baby’s saliva or urine within the first 21 days of life to reliably tell the difference [5].

Healthy, Full-Term Babies

If you have a history of CMV and your baby was born full-term and healthy, exposure to CMV through breast milk is generally not a reason to withhold your milk [6].

When healthy full-term infants acquire postnatal CMV, they rarely show any symptoms [7]. Their mature immune systems, combined with the protective antibodies passed to them through your breast milk, are typically strong enough to handle the virus. Because of this, medical guidelines generally encourage routine breastfeeding for full-term babies; the immense health and immune benefits far outweigh the very low risk of CMV complications [6][4]. (Note: If your full-term baby has a diagnosed immune disorder, always follow your doctor’s individualized advice.)

Premature and Very Low-Birth-Weight (VLBW) Babies

The risks are different for babies born very prematurely (especially before 32 weeks) or with a very low birth weight (under 1500 grams, or about 3.3 pounds) [3].

Clinically significant postnatal CMV disease is uncommon overall, but it is concentrated in these most immature infants [3]. Preterm infants have underdeveloped immune systems and missed out on the final weeks of pregnancy when mothers transfer the most protective antibodies. If a vulnerable preemie acquires CMV, they have a higher risk of developing severe symptoms [8]. These can include:

  • Sepsis-like illness: A severe, body-wide inflammatory response [8].
  • Respiratory issues: Such as pneumonia or worsening lung function [9].
  • Hepatitis: Inflammation of the liver [8].
  • Thrombocytopenia: Low levels of blood platelets (which help blood clot) [8].
  • Some observational studies note an association with longer hospitalizations [10].

Because of these risks, your NICU care team will carefully weigh the benefits of your breast milk against the risk of CMV transmission, looking closely at your baby’s specific situation [6].

Managing the Risk in the NICU

If your baby is high-risk, the NICU may suggest treating your breast milk or using alternatives. Do not attempt to pasteurize, heat, or alter your breast milk at home. These are precise medical procedures that require specialized hospital equipment.

  • Freezing and Thawing: Freezing milk (often at -20°C for a specific duration in the hospital) reduces the amount of live virus, though it does not completely eliminate the risk of transmission [11][12]. Some NICUs use this to balance nutritional benefits and infection risk [2].
  • Pasteurization (Heat Treatment): Exposing the milk to controlled heat (such as standard Holder pasteurization at 62.5°C for 30 minutes) is highly effective at destroying the CMV virus [13][14]. However, heat treatment can also break down some of the beneficial immune properties in breast milk [15].
  • Pasteurized Donor Human Milk or Formula: If your own milk cannot be used safely, the medical team may recommend pasteurized donor breast milk or formula [16][17]. Donor milk is often preferred to formula for very premature infants, but formula is also a safe alternative when donor milk is unsuitable or unavailable.

What to do while you wait:
If the NICU is deciding on a feeding plan, do not stop pumping. Continue to express, label, and store your milk exactly according to the hospital’s instructions. Pumping is crucial to establishing and maintaining your milk supply so that if and when your baby is ready for your milk, you will have it available.

It is completely normal to feel upset or disappointed if you are asked to delay feeding your baby your own milk. Remember that using donor milk or formula temporarily is not a failure, and it does not mean you won’t be able to provide breast milk later.

Common questions in this guide

Can I breastfeed my healthy full-term baby if I have CMV?
Usually, yes. For a healthy, full-term infant, breastfeeding is generally encouraged even when the mother has CMV antibodies because serious illness from CMV acquired through breast milk is very uncommon. If your baby has an immune disorder or another medical problem, follow the baby's clinician's individualized plan.
Why is CMV a bigger concern for premature or very small babies?
Very premature babies, especially those born before 32 weeks, and babies weighing under 1,500 grams have less mature immune systems. If they acquire CMV after birth, they have a higher risk of serious problems such as sepsis-like illness, breathing problems, liver inflammation, or low platelets.
Does a positive CMV blood test mean my breast milk is unsafe?
Usually, a positive CMV IgG blood test shows antibodies from a past infection and does not necessarily mean you are currently ill. It also does not mean every drop of milk contains infectious virus; shedding is often highest in the early weeks after birth and then declines. Ask your care team whether your result was an IgG test, IgM test, or milk test.
How can doctors tell whether a baby's CMV was present at birth?
If congenital CMV is a concern, doctors generally test the baby's saliva or urine during the first 21 days of life. Testing in that window helps distinguish infection passed during pregnancy from infection acquired after birth through milk.
Can freezing or pasteurizing breast milk remove CMV?
Freezing breast milk under a hospital's controlled conditions reduces live CMV but may not eliminate transmission risk. Controlled heat treatment, such as Holder pasteurization, is highly effective at destroying CMV but may reduce some helpful immune properties in the milk. Do not heat or pasteurize breast milk at home.
What should I do with my milk if the NICU is still deciding?
Continue pumping, labeling, and storing your milk exactly as the hospital instructs so you can maintain your supply. The team may use your milk after processing, pasteurized donor milk, or formula temporarily, depending on your baby's condition. Using an alternative feed for a time is not a failure.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Cytomegalovirus Infection.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my positive CMV test an IgG, IgM, or milk test, and does my baby need to be tested for congenital versus postnatal CMV within the first 21 days?
  2. 2.Given my baby's exact gestational age and weight, do the benefits of using my fresh breast milk outweigh the risks of CMV transmission?
  3. 3.Does our NICU have a specific protocol for processing breast milk (such as hospital-grade freezing or pasteurization) when the mother is CMV-seropositive?
  4. 4.When does the care team expect to start or resume feeding my baby my unprocessed milk, and will it require fortification?
  5. 5.What specific symptoms, warning signs, or test results in my baby would prompt you to evaluate for a CMV infection?

References

References (17)
  1. 1

    Correlates of postnatal human cytomegalovirus transmission in term babies in the first year.

    d'Angelo P, Zelini P, Zavaglio F, et al.

    Journal of medical virology 2023; (95(9)):e29105 doi:10.1002/jmv.29105.

    PMID: 37728300
  2. 2

    Incidence of Postnatal CMV Infection among Breastfed Preterm Infants: a Systematic Review and Meta-analysis.

    Park HW, Cho MH, Bae SH, et al.

    Journal of Korean medical science 2021; (36(12)):e84 doi:10.3346/jkms.2021.36.e84.

    PMID: 33783146
  3. 3

    Breast Milk-acquired Cytomegalovirus Infection in Premature or Very Low Birth Weight Infants: A Systematic Review.

    Valente Dias J, Marçal M, Tuna M

    The Pediatric infectious disease journal 2026; (45(6)):529-535 doi:10.1097/INF.0000000000005120.

    PMID: 41449583
  4. 4

    Minimal adverse outcomes of postnatal cytomegalovirus infection in term or moderate and late preterm infants.

    Chen J, Zhou Y, Tang J, et al.

    Frontiers in pediatrics 2023; (11()):1048282 doi:10.3389/fped.2023.1048282.

    PMID: 36816367
  5. 5

    Postnatal cytomegalovirus infection and its effect on hearing and neurodevelopmental outcomes among infants aged 3-10 months: A cohort study in Eastern Uganda.

    Okalany NRA, Mukunya D, Olupot-Olupot P, et al.

    PloS one 2025; (20(2)):e0318655 doi:10.1371/journal.pone.0318655.

    PMID: 39913500
  6. 6

    Postnatal Cytomegalovirus Risk Does Not Outweigh the Benefits of Mother's Raw Milk.

    Lawrence SM, Moreira ME, Neu J

    NeoReviews 2026; (27(7)):e414-e424 doi:10.1542/neo.27-7-027.

    PMID: 42379602
  7. 7

    Literature Review and an Italian Hospital Experience about Post-Natal CMV Infection Acquired by Breast-Feeding in Very Low and/or Extremely Low Birth Weight Infants.

    Garofoli F, Civardi E, Zanette S, et al.

    Nutrients 2021; (13(2)) doi:10.3390/nu13020660.

    PMID: 33670693
  8. 8

    Postnatal Cytomegalovirus Infection of Preterm and Very-low-birth-weight Infants Through Maternal Breast Milk: Does It Matter?

    Bimboese P, Kadambari S, Tabrizi SN, et al.

    The Pediatric infectious disease journal 2022; (41(4)):343-351 doi:10.1097/INF.0000000000003400.

    PMID: 34840311
  9. 9

    Postnatally acquired cytomegalovirus infection in extremely premature infants: how best to manage?

    Kadambari S, Whittaker E, Lyall H

    Archives of disease in childhood. Fetal and neonatal edition 2020; (105(3)):334-339 doi:10.1136/archdischild-2019-317650.

    PMID: 31615830
  10. 10

    Postnatal Cytomegalovirus Infection: Is it Important? A 10-Year Retrospective Case-control Study of Characteristics and Outcomes in Very Preterm and Very Low Birth Weight Infants.

    Minihan L, Lee Oei J, Bajuk B, Palasanthiran P

    The Pediatric infectious disease journal 2022; (41(7)):579-586 doi:10.1097/INF.0000000000003531.

    PMID: 35389941
  11. 11

    Vertically transmitted cytomegalovirus infection in newborn preterm infants.

    Balcells C, Botet F, Gayete S, et al.

    Journal of perinatal medicine 2016; (44(5)):485-90.

    PMID: 26845714
  12. 12

    Evaluation of the Freeze-Thawing Method in Reducing Viral Load of Cytomegalovirus in Breast Milk of Mothers of Preterm Infants.

    Hosseini M, Esmaili HA, Abdoli Oskouei S, et al.

    Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 2016; (11()):557-560 doi:10.1089/bfm.2016.0107.

    PMID: 27754707
  13. 13

    Strategies to reduce CMV infectivity in breastmilk to preterm babies - impact on transmission, nutrients, and bioactivity: a systematic review and meta-analysis.

    Singh A, Bartlett A, Clifford V, et al.

    Journal of perinatology : official journal of the California Perinatal Association 2025; (45(4)):426-437 doi:10.1038/s41372-025-02254-9.

    PMID: 40148583
  14. 14

    Short-term Pasteurization of Breast Milk to Prevent Postnatal Cytomegalovirus Transmission in Very Preterm Infants.

    Bapistella S, Hamprecht K, Thomas W, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (69(3)):438-444 doi:10.1093/cid/ciy945.

    PMID: 30407512
  15. 15

    Prevention of Cytomegalovirus Transmission via Breast Milk in Extremely Low Birth Weight Infants.

    Yoo HS, Sung SI, Jung YJ, et al.

    Yonsei medical journal 2015; (56(4)):998-1006 doi:10.3349/ymj.2015.56.4.998.

    PMID: 26069123
  16. 16

    Motivators and barriers to the acceptability of a human milk bank among Malaysians.

    Ramachandran K, Dahlui M, Nik Farid ND

    PloS one 2024; (19(3)):e0299308 doi:10.1371/journal.pone.0299308.

    PMID: 38437241
  17. 17

    Preservation of Anti-cytomegalovirus Activity in Human Milk Following High-Pressure Processing Compared to Holder Pasteurization.

    Kothari A, Pitino MA, Unger S, et al.

    Frontiers in nutrition 2022; (9()):918814 doi:10.3389/fnut.2022.918814.

    PMID: 35662924

This page is for informational purposes only and does not constitute medical advice about CMV or infant feeding. Your baby's NICU or pediatric team and a lactation consultant should guide decisions based on gestational age, birth weight, and overall health.